FDA Drug recall D-0131-2017
Testosterone 200 mg/Anastrazole 20mg Pellet, Compounded by: Wells Pharmacy Network
- FDA Drug
- Class II
- terminated
- Published 2016-11-16
On 2016-11-16 the FDA classified a Class II recall of Testosterone 200 mg/Anastrazole 20mg Pellet, Compounded by: Wells Pharmacy Network by Wells Pharmacy Network, citing superpotent and Subpotent drugs.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0131-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2016-09-19 |
| Published | 2016-11-16 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Wells Pharmacy Network |
| Distribution | n/a |
Product
Testosterone 200 mg/Anastrazole 20mg Pellet, Compounded by: Wells Pharmacy Network
Reason
Superpotent and Subpotent drugs
Identifiers
| code_info | Lot Number 08162016@5, BUD: 02/12/2017 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0131-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.